Integra LifeSciences Holdings Corporation
IART · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,747 | $3,404 | $4,654 | $5,674 |
| - Cash | $246 | $276 | $457 | $513 |
| + Debt | $1,985 | $1,682 | $1,615 | $1,651 |
| Enterprise Value | $3,485 | $4,810 | $5,812 | $6,812 |
| Revenue | $1,611 | $1,542 | $1,558 | $1,542 |
| % Growth | 4.5% | -1% | 1% | – |
| Gross Profit | $882 | $885 | $970 | $945 |
| % Margin | 54.8% | 57.4% | 62.3% | 61.2% |
| EBITDA | $193 | $256 | $385 | $366 |
| % Margin | 12% | 16.6% | 24.7% | 23.7% |
| Net Income | -$7 | $68 | $181 | $169 |
| % Margin | -0.4% | 4.4% | 11.6% | 11% |
| EPS Diluted | -0.09 | 0.84 | 2.16 | 1.98 |
| % Growth | -110.7% | -61.1% | 9.1% | – |
| Operating Cash Flow | $129 | $140 | $264 | $312 |
| Capital Expenditures | -$104 | -$67 | -$47 | -$48 |
| Free Cash Flow | $25 | $73 | $217 | $264 |